Facebook's virtual reality unit, Oculus, has announced that it’s shutting down its in-house film studio—news that may be the start of a bit of belt-tightening in the industry, as more firms try to make VR profitable.
Story Studio, as it was called, was part of an attempt on the part of Oculus, which makes the impressive Rift headset, to foster a rich and varied buffet of content for VR users that isn't restricted to gameplay. And in its announcement, the company—which was acquired by Facebook in 2014 for over $2 billion—said that it will commit $50 million to funding other filmmakers and developers that are building non-gaming content for VR.
But the move could be read as a further sign of VR's struggles to break into the mainstream. As we reported at the end of last year, 2016 was supposed to be a banner year for VR, but sales ultimately proved sluggish. And Oculus appears to be faring worse than most: having suffered the indignity of having to close down a string of in-store demo stations due to lack of demand, it later slashed $200 off the price of its Rift headset and motion controllers to keep up with the likes of Sony.
Then there’s the little matter of that painful lawsuit, in which video game publisher ZeniMax took Oculus to task over alleged intellectual property theft. Ultimately a Texas jury found Palmer Luckey, cofounder of Oculus, guilty of failing to comply with a non-disclosure agreement that he signed with ZeniMax, though he wasn’t found to have stolen trade secrets. That little oopsie cost Oculus $250 million.
With the wider industry struggling to convince people to buy the devices, VR companies will have to take a hard look at their offerings. That's likely to result in trimming some fat and distilling their technology down into something that consumers actually want to buy. It’s just a shame that nobody quite knows what that is yet.
Why China is still obsessed with disinfecting everything
Most public health bodies dealing with covid have long since moved on from the idea of surface transmission. China’s didn’t—and that helps it control the narrative about the disease’s origins and danger.
These materials were meant to revolutionize the solar industry. Why hasn’t it happened?
Perovskites are promising, but real-world conditions have held them back.
Crypto is weathering a bitter storm. Some still hold on for dear life.
When a cryptocurrency’s value is theoretical, what happens if people quit believing?
Anti-aging drugs are being tested as a way to treat covid
Drugs that rejuvenate our immune systems and make us biologically younger could help protect us from the disease’s worst effects.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.